Companion Animals

Dog Mitral Valve Disease Management

Degenerative mitral valve disease is the most common heart disease in dogs, requiring staged management to maximize quality and length of life as the condition progresses.

Key Facts

Welfare Considerations

DMVD causes progressive welfare compromise as leaking mitral valves reduce cardiac efficiency, eventually causing heart failure with exercise intolerance, coughing, and respiratory distress. Early-stage disease causes no clinical signs, making it detectable only through cardiac examination. The transition to heart failure represents a significant welfare deterioration with breathlessness and exercise intolerance affecting all aspects of daily life. Pimobendan treatment in the preclinical stage demonstrably delays this progression, extending comfortable life. The EPIC trial showed preclinical treatment extended time to heart failure by 15 months. End-stage heart failure with refractory fluid accumulation requires compassionate end-of-life decision-making when quality of life becomes unacceptable.

What You Can Do